Companies / Japan
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Multinationals Eye Japan's Cancer Market
August 2006 | Market Trend AnalysisSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
According to industry experts, prospects for a significant expansion of Japan's US$3.2bn cancer market are set to improve significantly. New product launches by foreign-owned companies, and a health ministry drive to improve outcomes, are laying the foundations for further market